Navigation Links
Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Date:11/6/2008

BGC 945 Builds Upon a Proven Class of Drugs With Greater Tumor Selectivity

EMERYVILLE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has in-licensed a novel targeted oncology compound, BGC 945, from BTG International Limited based in the United Kingdom. Under the terms of the agreement, Onyx will obtain a worldwide license for BGC 945 and all of its related patents. Onyx will receive exclusive worldwide marketing rights and will be responsible for all product development and commercialization activities. BTG will receive a $13 million upfront payment, and payments of up to $72 million upon the attainment of certain global development and regulatory milestones, plus additional milestone payments upon the achievement of certain marketing approvals and commercial milestones. BTG will also receive royalties on future product sales.

"In-licensing a promising compound, such as BGC 945, with potential application in several large tumor markets strategically strengthens Onyx's pipeline and expands our portfolio as a growing biopharmaceutical company," said Tony Coles, M.D., president and chief executive officer of Onyx. "With proven success in developing and commercializing Nexavar as one of the leading targeted oncology therapies, we are well positioned to maximize BGC 945's full potential in a variety of tumors."

BGC 945 (ONX 0801) is designed to work by combining two proven approaches to improving outcomes for cancer patients. These include receptor-mediated targeting of tumor cells and inhibition of thymidylate synthase, a key enzyme involved in cell growth and division. BGC 945 (ONX 0801) targets malignant cells that overexpress the alpha-folate receptor, which is
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
2. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
3. Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
4. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
6. Onyx Pharmaceuticals to Present at the 2008 Credit Suisse Health Care Conference
7. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
8. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
9. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
10. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
11. VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ewswire/ -- For more than 20 years,researchers all...nt of a,Brain-Computer Interface (BCI). This is a ... a computer. Such a system enables completely para...s in their environment just by,mental activity. Du...ised by,the researchers themselves to use such BCI...
(Date:11/9/2009)...research industry first, allowing veterinary resea...ety study data to be managed in one software appli...J (PRWEB) November 9, 2009 -- Xybion Medical Syste...rade; VM, an integrated enterprise software soluti...care of veterinary research subjects. Pristima&tra...
(Date:11/6/2009)...Microbix Biosystems Inc. (the "Company") announces...ification of Annual Filings of William Gastle, the... Financial Officer (the "Officer,s Certificates") ...al audited financial statements for the year ended...iled the annual financial statements for the year ...
(Date:11/6/2009)...stCall/ -- ,, 3Q09 Corporate Highlights: ,...ting Authorization to Astellas Pharma Europe Ltd. ...s activities Expanded management team to include ..., Commercial Operations Appointed Bradford S. Goo...rman , Upcoming 2009 Milestones: ,, F...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10
...ISON, N.J., June 9 Davie Floyd, Director of Train...roup, an Informed Medical,Communications company, ...&,Biotech Trainers 37th Annual Conference in Orlan... through influential dialogue, Floyd and Bresette,...ialogue: Advanced,Influencing Skill for Changing T...
...dustry veteran joins growing specialty online empl... expansion, FORT WORTH, Texas, June 9 onTargetj... announced today the appointment of,Michael J. "Mi...ighted to be part of the onTargetjobs team as it i... said Mr. Tansey. "The acquisition of,RegionalHelp...
...YMOUTH MEETING, Pa., June 9 /Xinhua-PRNewswire-Fir... ) ("BMP Sunstone" or the "Company") today,announc...unstone,Corporation and a member of the Board of D...f Operating Officer of BMP Sunstone Corporation,ef...dent of BMP Sunstone since April 2008 and,played a...
Other Biology Technology:Experts From The Peer Group Provide Training on Dialogue-Based Influence at the SPBT Annual Conference 2onTargetjobs Announces Appointment of Michael Tansey as New CEO 2BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer 2BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer 3
(Date:11/6/2009)...re/ -- Auburn Hills, MI-based Law Enforcement Inte... locker system and patent-pending Biometric Access...of Health and Human Services, National Institutes ... system will support the NIH,s entire police force...edical research agency. The project is expected t...
(Date:11/5/2009)...t Yale University have developed synthetic molecul... to HIV and HIV-infected cells, as well as to pros...e in the Journal of the American Chemical Society...these diseases. , The molecules called "antibo..."antibody-recruiting molecule targeting prostate c...
(Date:11/4/2009)...l science) , United States Using Less Water To...han it did 35 years ago, despite a 30 percent popu...attributable to alternative cooling methods at pow...ccording to the latest USGS water use report, near...s to cooling thermoelectric power plants. Irrigati...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Synthetic Biology Project receives 2 National Science Foundation grants 10033 1Web based innovation improves eases agricultural terrace design 10030 1Web based innovation improves eases agricultural terrace design 10030 2Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 1Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 2Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 3Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 4Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 5Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 6Reportlinker Adds Retail Clinics and the In Store Healthcare Market 2009 3A Bright Spot in the Current Economy 3F Report 58022 7
... team of researchers, led by the University of She...d to past natural climate extremes. The new resear... future global warming. , With fishing pressure...concern over the current sustainability of cod and...he journal, Proceedings of the Royal Society B, sh...
...elines Toolset is presented to the public and pres... , When: Public symposium 1pm to 5:15pm, Wednesday...rd Street, University of Auckland city campus. , T...m on Wednesday 14 November. Scientists will be ava...s by arrangement. , With evidence in hand we can ...
...ember 8, 2007) Estimates are that up to 70 millio...inary incontinence. A major cause of urinary incon...muscle, often associated with trauma during child ...aging. According to a new study, those suffering f...ting incontinence may eventually find relief throu...
Other Biology News:Ice age imprint found on cod DNA 2How much fish have we got? 2How much fish have we got? 3
Attoglow Western Blot Analysis Kit: Millennium Enhancer from BioChain
Mouse GM-CSF ELISpot Kit from R&D Systems
Cultrex 3D Culture Matrix Rat Collagen I from R&D Systems
mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis from Molecular Probes (Invitrogen)
Biology Products: